Learn more in the 2025 Employer Health Benefits Survey: GLP-1 weight-loss drugs coverage by large employers Coverage of GLP-1 weight-loss drugs is growing among the largest employers (5000+ workers), now at 43%
We summarised the current evidence and available recommendations from the ASA and ESAIC to support clinicians in the perioperative management of patients receiving SGLT2 inhibitors, GLP-1RAs and related therapies (Table 2)
Wegovy is approved for weight loss in some teens over 12, but mental health support is extra important in younger patients
Endoscopic ultrasound-guided drainage of pancreatic walled-off necrosis using 20-mm versus 15-mm lumen-apposing metal stents: An international, multicenter, case-matched study
Im not trying to be Arnold Schwarzenegger, the bodybuilder
Glutathione is a natural skin antioxidant that helps inhibit the enzyme that forms pigment